Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

Vasculitis Symposium & CANVASC

Research Course Committee

Thursday, 8 October 2015 from 7:30 AM to 5:00 PM (MDT)

Vasculitis Symposium & CANVASC
Available Dates
No tickets available for upcoming dates

Ticket Information

Type End Quantity
General Participant Ended Free  

Share Vasculitis Symposium & CANVASC

Event Details

OCTOBER 8, 2015 - Thursday (07:30-1700)

New Frontiers in Understanding and Treating Childhood and Adult Vasculitis

This symposium is an opportunity to learn about recent discoveries in clinical and translational research and innovations in care for patients with vasculitis aiming to improve the long term outcomes. 

Topics include:

  • Treatment and outcome of ANCA associated vasculitis in 2015
  • Lung disease in vasculitis
  • Optimizing care for patients with vasculitis
  • CNS disease in vasculitis
  • Clinical research in adult vasculitis
  • Discoveries in childhood vasculitis
  • Clinical research in childhood systemic vasculitis


Keynote presentation:  New frontiers in vasculitis research - Presented by: Charles Jennette, Kenneth M. Brinkhous Distinguished Professor and Chair, Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, NC, USA

 


OCTOBER 9, 2015 - Friday (08:00-13:00)

CanVASC Research Meeting 

For CanVasc core members and any research fellows or vasculitis physicians interested in vasculitis research in Canada.

Have questions about Vasculitis Symposium & CANVASC? Contact Research Course Committee

When & Where


Alberta Children's Hospital - Telus Theatre (4th Floor)
2888 Shaganappi Trail Northwest
Calgary, AB T3B 6A8
Canada

Thursday, 8 October 2015 from 7:30 AM to 5:00 PM (MDT)


  Add to my calendar

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.